Related references
Note: Only part of the references are listed.Dioscin inhibits the growth of human osteosarcoma by inducing G2/M-phase arrest, apoptosis, and GSDME-dependent cell death in vitro and in vivo
Qiuyue Ding et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Gliosarcoma Is Driven by Alterations in PI3K/Akt, RAS/MAPK Pathways and Characterized by Collagen Gene Expression Signature
Bartosz Wojtas et al.
CANCERS (2019)
Complex Systems Biology Approach in Connecting PI3K-Akt and NF-κB Pathways in Prostate Cancer
Eswar Shankar et al.
CELLS (2019)
Insights into autophagy machinery in cells related to skin diseases and strategies for therapeutic modulation
Yujia Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Caspase-3-mediated GSDME activation contributes to cisplatin- and doxorubicin-induced secondary necrosis in mouse macrophages
Feng-Yi Mai et al.
CELL PROLIFERATION (2019)
Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma
Chune Yu et al.
FRONTIERS IN IMMUNOLOGY (2019)
Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives
Michela Croce et al.
CANCERS (2019)
Hsp90 Heterocomplexes Regulate Steroid Hormone Receptors: From Stress Response to Psychiatric Disease
Jeremy D. Baker et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Sanshool improves UVB-induced skin photodamage by targeting JAK2/STAT3-dependent autophagy
Dan Hao et al.
CELL DEATH & DISEASE (2019)
EMP2 acts as a suppressor of melanoma and is negatively regulated by mTOR-mediated autophagy
Manyi Wang et al.
JOURNAL OF CANCER (2019)
Organocatalytic diastereoselective [3+2] cyclization of MBH carbonates with dinucleophiles: synthesis of bicyclic imidazoline derivatives that inhibit MDM2-p53 interaction
Hong-Ping Zhu et al.
CHEMICAL COMMUNICATIONS (2019)
Local delivery of arsenic trioxide nanoparticles for hepatocellular carcinoma treatment
Jian Hu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Design, synthesis and molecular mechanisms of novel dual inhibitors of heat shock protein 90/phosphoinositide 3-kinase alpha (Hsp90/PI3Kα) against cutaneous melanoma
Feifei Qin et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Flaccidoxide-13-Acetate Extracted from the Soft Coral Cladiella kashmani Reduces Human Bladder Cancer Cell Migration and Invasion through Reducing Activation of the FAK/PI3K/AKT/mTOR Signaling Pathway
Choo-Aun Neoh et al.
MOLECULES (2018)
Asymmetric synthesis of tetrahydroisoquinoline-fused spirooxindoles as Ras- GTP inhibitors that inhibit colon adenocarcinoma cell proliferation and invasion
Qian Zhao et al.
CHEMICAL COMMUNICATIONS (2018)
Design, synthesis, and biological evaluation of polo-like kinase 1/eukaryotic elongation factor 2 kinase (PLK1/EEF2K) dual inhibitors for regulating breast cancer cells apoptosis and autophagy
Zhaoping Pan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery of a self-assembling and self-adjuvant lipopeptide as a saccharide-free peptide vaccine targeting EGFRvIII positive cutaneous melanoma
Yujuan Chen et al.
BIOMATERIALS SCIENCE (2018)
Application of organocatalysis in bioorganometallic chemistry: asymmetric synthesis of multifunctionalized spirocyclic pyrazolone-ferrocene hybrids as novel RalA inhibitors
Yuehua Zhang et al.
ORGANIC CHEMISTRY FRONTIERS (2018)
Reversal of Resistance in Targeted Therapy of Metastatic Melanoma: Lessons Learned from Vemurafenib (BRAFV600E-Specific Inhibitor)
Antoni Xavier Torres-Collado et al.
CANCERS (2018)
Cathepsin B regulates non-canonical NLRP3 inflammasome pathway by modulating activation of caspase-11 in Kupffer cells
Nan Chen et al.
CELL PROLIFERATION (2018)
DNMT and HDAC inhibitors together abrogate endotoxemia mediated macrophage death by STAT3-JMJD3 signaling
Saheli Samanta et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
The HSP90 Family: Structure, Regulation, Function, and Implications in Health and Disease
Abdullah Hoter et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Tanshinone IIA Attenuates Insulin Like Growth Factor 1-Induced Cell Proliferation in PC12 Cells through the PI3K/Akt and MEK/ERK Pathways
Haitao Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
In Vivo Genome Editing as a Therapeutic Approach
Beatrice Xuan Ho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Ursolic Acid-Induced Apoptosis via Regulation of the PI3K/Akt and MAPK Signaling Pathways in Huh-7 Cells
Kwong-Chiu Lee et al.
MOLECULES (2018)
Hsp90 Stabilizes SIRT1 Orthologs in Mammalian Cells and C-elegans
Minh Tu Nguyen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
Yupeng Wang et al.
NATURE (2017)
The HSP90 chaperone machinery
Florian H. Schopf et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
GSDME as an executioner of chemotherapy-induced cell death
Xiaoliang Yu et al.
SCIENCE CHINA-LIFE SCIENCES (2017)
Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death
Corey Rogers et al.
NATURE COMMUNICATIONS (2017)
AR Signaling and the PI3K Pathway in Prostate Cancer
Megan Crumbaker et al.
CANCERS (2017)
PI3K Signaling in Tissue Hyper-Proliferation: From Overgrowth Syndromes to Kidney Cysts
Maria Chiara De Santis et al.
CANCERS (2017)
State of the Science on Prevention and Screening to Reduce Melanoma Incidence and Mortality: The Time Is Now
Mary K. Tripp et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis
Xin Chen et al.
CELL RESEARCH (2016)
Targeting Programmed Cell Death Using Small-Molecule Compounds to Improve Potential Cancer Therapy
Bowen Ke et al.
MEDICINAL RESEARCH REVIEWS (2016)
Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
Xing Liu et al.
NATURE (2016)
Mapping the Hsp90 Genetic Network Reveals Ergosterol Biosynthesis and Phosphatidylinositol-4-Kinase Signaling as Core Circuitry Governing Cellular Stress
Teresa R. O'Meara et al.
PLOS GENETICS (2016)
Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion
Wan-ting He et al.
CELL RESEARCH (2015)
Multiclass Comparative Virtual Screening to Identify Novel Hsp90 Inhibitors: A Therapeutic Breast Cancer Drug Target
Nageswara Rao Dunna et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Jianjin Shi et al.
NATURE (2015)
Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy
Stuart J. Gallagher et al.
CANCERS (2015)
HDAC8-Mediated Epigenetic Reprogramming Plays a Key Role in Resistance to Anthrax Lethal Toxin-Induced Pyroptosis in Macrophages
Soon-Duck Ha et al.
JOURNAL OF IMMUNOLOGY (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Polygonatum odoratum lectin induces apoptosis and autophagy via targeting EGFR-mediated Ras-Raf-MEK-ERK pathway in human MCF-7 breast cancer cells
Liang Ouyang et al.
PHYTOMEDICINE (2014)
HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
Katerina Sidera et al.
Recent Patents on Anti-Cancer Drug Discovery (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Destabilization of PDK1 by Hsp90 inactivation suppresses hepatitis C virus replication through inhibition of PRK2-mediated viral RNA polymerase phosphorylation
Mi-Gyeong Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities
R. Sinha et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
SNX-2112, an Hsp90 inhibitor, induces apoptosis and autophagy via degradation of Hsp90 client proteins in human melanoma A-375 cells
Kai-Sheng Liu et al.
CANCER LETTERS (2012)
Regulation of inflammasome signaling
Vijay A. K. Rathinam et al.
NATURE IMMUNOLOGY (2012)
Vemurafenib: the first drug approved for BRAF-mutant cancer
Gideon Bollag et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941
Florence I. Raynaud et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Pyroptosis: host cell death and inflammation
Tessa Bergsbaken et al.
NATURE REVIEWS MICROBIOLOGY (2009)
NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations
Violeta Serra et al.
CANCER RESEARCH (2008)
Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
Pieter J. A. Eichhorn et al.
CANCER RESEARCH (2008)
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
Amancio Carnero et al.
CURRENT CANCER DRUG TARGETS (2008)
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
Sauveur-Michel Maira et al.
MOLECULAR CANCER THERAPEUTICS (2008)
PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML
S. Park et al.
LEUKEMIA (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
Jeffrey A. Engelman et al.
NATURE MEDICINE (2008)
AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL
E. Weisberg et al.
BRITISH JOURNAL OF CANCER (2006)
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
Qi-Wen Fan et al.
CANCER CELL (2006)
Glivec (ST1571, Imatinib), a rationally developed, targeted anticancer drug
R Capdeville et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
DFNA5 (ICERE-1) contributes to acquired etoposide resistance in melanoma cells
H Lage et al.
FEBS LETTERS (2001)
Degradation of heterotrimeric Gαo subunits via the proteosome pathway is induced by the hsp90-specific compound geldanamycin
L Busconi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
